A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
Korean Journal of Ophthalmology
;
: 29-34, 2010.
Article
in English
| WPRIM
| ID: wpr-22610
ABSTRACT
PURPOSE:
Our goal was to investigate the effects of inhibition of transglutaminase 2 (TGase 2) on endotoxin-induced uveitis (EIU)METHODS:
EIU was induced in female Lewis rats by single footpad injections of 200 microgram of lipopolysaccharide (LPS). TGase 2 inhibitors were administered intraperitoneally 30 minutes before and at the time of LPS administration. Rats were sacrificed 24 hours after injection, and the effects of the TGase 2 inhibitors were evaluated by the number of intraocular inflammatory cells present on histologic sections and by measuring the TGase 2 activity and TGase products in the aqueous humor (AqH). TGase 2 substrates were also assayed in AqH from uveitis patients.RESULTS:
Clinical indications of EIU, the number of cells present on histologic sections, and TGase 2 activity in AqH increased in a time-dependent manner, peaking 24 hours after LPS injection. Inflammation in EIU was significantly reversed by treatment with TGase inhibitors. A 23-kDa cross-linked TGase substrate was identified in the AqH from EIU rats and uveitis patients. MALDI-TOF analysis showed that this substrate in uveitis patients was human Ig kappa chain C region.CONCLUSIONS:
TGase 2 activity and its catalytic product were increased in the AqH of EIU rats. TGase 2 inhibition attenuated the degree of inflammation in EIU. Safe and stable TGase inhibitors may have great potential for the treatment of inflammatory uveitis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Rats, Inbred Lew
/
Uveitis
/
Transglutaminases
/
Lipopolysaccharides
/
Disease Progression
/
GTP-Binding Proteins
/
Enzyme Inhibitors
Limits:
Animals
Language:
English
Journal:
Korean Journal of Ophthalmology
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS